ID   MARHB_RAT               Reviewed;         398 AA.
AC   A6P320;
DT   10-JUN-2008, integrated into UniProtKB/Swiss-Prot.
DT   21-AUG-2007, sequence version 1.
DT   24-JUL-2024, entry version 94.
DE   RecName: Full=E3 ubiquitin-protein ligase MARCHF11;
DE            EC=2.3.2.27;
DE   AltName: Full=Membrane-associated RING finger protein 11;
DE   AltName: Full=Membrane-associated RING-CH protein XI;
DE            Short=MARCH-XI;
DE   AltName: Full=RING-type E3 ubiquitin transferase MARCHF11 {ECO:0000305};
GN   Name=Marchf11; Synonyms=March11;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INTERACTION WITH AP1M1 AND LIN7A, AND MUTAGENESIS OF CYS-169;
RP   CYS-182; CYS-184; TYR-367 AND VAL-398.
RC   TISSUE=Testis;
RX   PubMed=17604280; DOI=10.1074/jbc.m700414200;
RA   Morokuma Y., Nakamura N., Kato A., Notoya M., Yamamoto Y., Sakai Y.,
RA   Fukuda H., Yamashina S., Hirata Y., Hirose S.;
RT   "MARCH-XI, a novel transmembrane ubiquitin ligase implicated in ubiquitin-
RT   dependent protein sorting in developing spermatids.";
RL   J. Biol. Chem. 282:24806-24815(2007).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that mediates polyubiquitination
CC       of CD4. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-
CC       conjugating enzyme in the form of a thioester and then directly
CC       transfer the ubiquitin to targeted substrates. May play a role in
CC       ubuquitin-dependent protein sorting in developmenting spermatids.
CC       {ECO:0000269|PubMed:17604280}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts (YXXL motif) with AP1M1. Interacts (via PDZ-binding
CC       motif) with LIN7A. Interacts with unidentified fucose glycoproteins.
CC       {ECO:0000269|PubMed:17604280}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:17604280}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:17604280}.
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in testis. Present in early
CC       developing spermatids. Not present in spermatogonia, spermatocytes or
CC       somatic cells (i.e. peritubular, Leydig, and Sertoli cells). Present in
CC       early round spermatids at step 4, remains until step 11, then it
CC       decreases at steps 12-15, and diminishes after step 16 (at protein
CC       level). Also expressed at lower level in brain.
CC       {ECO:0000269|PubMed:17604280}.
CC   -!- DOMAIN: The RING-CH-type zinc finger domain is required for E3 ligase
CC       activity.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB048841; BAF68985.1; -; mRNA.
DR   RefSeq; NP_001095298.1; NM_001101828.1.
DR   AlphaFoldDB; A6P320; -.
DR   SMR; A6P320; -.
DR   BioGRID; 270867; 3.
DR   STRING; 10116.ENSRNOP00000035881; -.
DR   iPTMnet; A6P320; -.
DR   PhosphoSitePlus; A6P320; -.
DR   PaxDb; 10116-ENSRNOP00000035881; -.
DR   GeneID; 499558; -.
DR   KEGG; rno:499558; -.
DR   UCSC; RGD:1559945; rat.
DR   AGR; RGD:1559945; -.
DR   CTD; 441061; -.
DR   RGD; 1559945; Marchf11.
DR   eggNOG; KOG1609; Eukaryota.
DR   InParanoid; A6P320; -.
DR   OrthoDB; 1342875at2759; -.
DR   PhylomeDB; A6P320; -.
DR   UniPathway; UPA00143; -.
DR   PRO; PR:A6P320; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   CDD; cd16810; RING_CH-C4HC3_MARCH11; 1.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR047906; MARCHF11_RING_CH-C4HC3.
DR   InterPro; IPR046356; MARCHF4/9/11.
DR   InterPro; IPR011016; Znf_RING-CH.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR46053; E3 UBIQUITIN-PROTEIN LIGASE MARCH4-LIKE; 1.
DR   PANTHER; PTHR46053:SF1; E3 UBIQUITIN-PROTEIN LIGASE MARCHF11; 1.
DR   Pfam; PF12906; RINGv; 1.
DR   SMART; SM00744; RINGv; 1.
DR   SUPFAM; SSF101447; Formin homology 2 domain (FH2 domain); 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   PROSITE; PS51292; ZF_RING_CH; 1.
PE   1: Evidence at protein level;
KW   Cytoplasmic vesicle; Membrane; Metal-binding; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix; Ubl conjugation pathway;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..398
FT                   /note="E3 ubiquitin-protein ligase MARCHF11"
FT                   /id="PRO_0000339346"
FT   TRANSMEM        241..261
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        274..294
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         158..218
FT                   /note="RING-CH-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   REGION          1..158
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           367..370
FT                   /note="YXXL motif"
FT   MOTIF           395..398
FT                   /note="PDZ-binding"
FT   COMPBIAS        17..47
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        66..80
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        134..154
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         166
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         169
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         182
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         184
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         192
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         195
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         208
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   BINDING         211
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00623"
FT   MUTAGEN         169
FT                   /note="C->S: Abolishes ubiquitin ligase activity; when
FT                   associated with S-182 and S-184."
FT                   /evidence="ECO:0000269|PubMed:17604280"
FT   MUTAGEN         182
FT                   /note="C->S: Abolishes ubiquitin ligase activity; when
FT                   associated with S-169 and C-184."
FT                   /evidence="ECO:0000269|PubMed:17604280"
FT   MUTAGEN         184
FT                   /note="C->S: Abolishes ubiquitin ligase activity; when
FT                   associated with S-169 and C-182."
FT                   /evidence="ECO:0000269|PubMed:17604280"
FT   MUTAGEN         367
FT                   /note="Y->A: Abolishes interaction with AP1M1."
FT                   /evidence="ECO:0000269|PubMed:17604280"
FT   MUTAGEN         398
FT                   /note="Missing: LIN7A."
FT                   /evidence="ECO:0000269|PubMed:17604280"
SQ   SEQUENCE   398 AA;  44085 MW;  EB3CC606A44DE800 CRC64;
     MSDEGSKRGS RADSLEAEPP LPPPPPPPPP GESSLVPTSP RYRPPLPAPL ERIVGSGEPP
     VELAPRRKGE PLPPLPPSRL PGDQEVSAAG DSCEGPRRLP EVKLPEAAAG KGSPAEPEAG
     ACREGERRGT GDQPETRSVY SSRSSSSGGS GDQRSGHQHQ HHQPICKICF QGAEQGELLN
     PCRCDGSVRY THQLCLLKWI SERGSWTCEL CCYRYHVTAI KMKQPCQWQS ISITLVEKVQ
     MIAVILGSLF LIASVTWLLW SAFSPYAVWQ RKDILFQICY GMYGFMDLVC IGLIVHEGAA
     VYRVFKRWRA VNLHWDVLNY DKATDIEESS RGESSTSRTL WLPLSALRNR NLVHPTQLTS
     PRFQCGYVLL HLFNRMRAHE DVSEDNGSGE VVMRVTSV
//
